Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where 10x Genomics is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- SCHEDULE 13G/A2026-10-07SCHEDULE 13G/A
- SCHEDULE 13G2026-09-08SCHEDULE 13G
- SCHEDULE 13G/A2026-08-14SCHEDULE 13G/A
- 10-Q2026-08-07Quarterly report
- 8-K2026-08-06Current report (material event)
- 8-K2026-06-08Current report (material event)
- 10-Q2026-05-08Quarterly report
- 8-K2026-05-07Current report (material event)
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- SCHEDULE 13G2026-04-28SCHEDULE 13G
- DEFA14A2026-04-24DEFA14A
- DEF 14A2026-04-24Proxy statement
- SCHEDULE 13G/A2026-03-25SCHEDULE 13G/A
- SCHEDULE 13G/A2026-03-24SCHEDULE 13G/A
- SCHEDULE 13G/A2026-03-06SCHEDULE 13G/A
- S-82026-02-13Employee stock plan
- 10-K2026-02-13Annual report
- 8-K2026-02-12Current report (material event)
- 8-K2026-01-12Current report (material event)
- SCHEDULE 13G/A2026-01-08SCHEDULE 13G/A
- 8-K2025-11-14Current report (material event)
- SCHEDULE 13G/A2025-11-13SCHEDULE 13G/A
- 10-Q2025-11-07Quarterly report
- 8-K2025-11-06Current report (material event)
- SCHEDULE 13G/A2025-11-05SCHEDULE 13G/A
- SCHEDULE 13G/A2025-11-04SCHEDULE 13G/A
- SCHEDULE 13G/A2025-10-30SCHEDULE 13G/A
- SCHEDULE 13G/A2025-10-27SCHEDULE 13G/A
- SCHEDULE 13G2025-08-13SCHEDULE 13G
- SCHEDULE 13G/A2025-08-12SCHEDULE 13G/A
- 10-Q2025-08-08Quarterly report
- 8-K2025-08-07Current report (material event)
- SCHEDULE 13G/A2025-08-07SCHEDULE 13G/A
- SCHEDULE 13G/A2025-08-06SCHEDULE 13G/A
- SCHEDULE 13G2025-07-31SCHEDULE 13G
- SCHEDULE 13G/A2025-07-16SCHEDULE 13G/A
- 8-K2025-06-05Current report (material event)
- 8-K2025-05-14Current report (material event)
- SCHEDULE 13G/A2025-05-14SCHEDULE 13G/A
- SCHEDULE 13G/A2025-05-12SCHEDULE 13G/A
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.